Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30068171HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068172HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068173HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068174HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068175HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068176HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS30068177HIVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS20061429HPVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS20031498HPVENSG00000157764.14protein_codingBRAFYesNo673P15056
TVIS20026571HPVENSG00000157764.14protein_codingBRAFYesNo673P15056
TCGA Plot Options
Drug Information
GeneBRAF
DrugBank IDDB08912
Drug NameDabrafenib
Target IDBE0000634
UniProt IDP15056
Regulation Typeinhibitor
PubMed IDs23621583
CitationsGibney GT, Zager JS: Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies. Expert Opin Drug Metab Toxicol. 2013 Jul;9(7):893-9. doi: 10.1517/17425255.2013.794220. Epub 2013 Apr 29.
GroupsApproved; Investigational
Direct ClassificationSulfanilides
SMILESCC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL2028663